Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Vietnam’s Gene Solutions is set to complete a $50 million Series C funding round to support its upcoming Hong Kong IPO for global growth.
PRIVATEJun 01, 2026•2 months ago
Amount Raised
$50 Million
Round Type
Series C
CharlottesvilleBiotechnology
Description
Gene Solutions, a Vietnamese diagnostic testing startup, is preparing for a Hong Kong IPO and aims to finalize a $50 million Series C round. The company specializes in non-invasive prenatal testing and cancer screening. CEO Nguyen Hoai Nghia stated the goal is to raise about $100 million through the share offering. They aim for a valuation of around $800 million and to meet revenue targets of $90 million by year-end.
Company Information
Company
Gene Solutions
Location
123 E. Main Street
Charlottesville, Virginia, United States
About
Gene Solutions represents a breakthrough diagnostic and therapeutic approach to Central Nervous System disease indications utilizing mitochondrial genomics to identify disease-causing mitochondrial mutations. These mutations, which have been validated as highly indicative in Parkinson's Disease, will form the basis of Gene Solutions diagnostics and therapeutic development platforms.
Predictive Intelligence
Strategic
ML-powered predictions for Gene Solutions's next move
CharlottesvilleBiotechnology